Kiromic Biopharma Inc (KRBP) Return on Investment ROI from the fourth quarter of 2024 to fourth quarter of 2023 and for the year 2024, average high and low, overall ranking from Dec 31 2024 to Dec 31 2023 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Kiromic Biopharma Inc   (KRBP)


Kiromic Biopharma Inc's ROI from its fourth quarter of 2024 to the fourth quarter of 2023 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Kiromic Biopharma Inc's ROI in the fourth quarter of 2024?
Due to the stockholders deficit and subsequent negative measured investments, it was not possible to calculate Kiromic Biopharma Inc 's return on investment (ROI) in its fourth quarter of 2024

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Dec 31 2024)
IV. Quarter		 (Sep 30 2024)
III. Quarter		 (Jun 30 2024)
II. Quarter		 (Mar 31 2024)
I. Quarter		 (Dec 31 2023)
IV. Quarter
Y / Y Investment Change TTM - - - - -
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions -12 -9 -5 -6 -8
Return On Investment (TTM) - - - - -
KRBP's Overall Ranking # # # # #
Seq. Investment Change TTM - - - - -
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -27 -25 -22 -22 -21

KRBP Company Profile >> Back to KRBP Roi Comparisons >> See Annual KRBP Return On Investment



Return On Investment KRBP's Ranking
Within: No.
Industry #
Sector #
Overall #

Return On Investment Statistics
High Average Low
0 %
0 %
0 %
 







Financial Statements
Kiromic Biopharma Inc's IV. Quarter Investments $ -12 Millions KRBP's Balance sheet
Kiromic Biopharma Inc's IV. Quarter Income $ -6 Millions Quarterly KRBP's Income Statement
KRBP's Income by Division See KRBP's Income by Division


KRBP Annual Return On Investment (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021		 (Dec 31 2020)
2020
Total Investments in Millions -12 -8 -1 27 11
Y / Y Investment Growth - - - 140.45 % -
Net Income in Millions -27 -21 -35 -26 -19
Y / Y Net Income Growth - - - - -
Annual Return On Investment - - - -93.66 % -168.98 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Biotechnology & Pharmaceuticals Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
KRBP's Roi Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for KRBP's Competitors
Subscribers only: Roi for Kiromic Biopharma Inc's Suppliers
Subscribers only: Return On Investment for KRBP's Customers

Other Ratios
KRBP's Roa KRBP's Inventory Turnover Ratio KRBP's Growth Rates KRBP's Dividend Statistics
KRBP's Profitability Ratios KRBP's Asset Turnover Ratio KRBP's Dividend Growth
KRBP's Roe KRBP's Valuation Ratios KRBP's Financial Strength Ratios KRBP's Dividend Payout Ratio



Companies with similar Return On Investment at Dec 31 2024, within Healthcare Sector ROI
Inhibrx Biosciences Inc   894.58 %
Traws Pharma inc   659.53 %
Ir med Inc   445.51 %
Polypid Ltd  278.02 %
Inspira Technologies Oxy B H N Ltd  235.17 %
Camp4 Therapeutics Corporation  206.47 %
Alumis inc   156.42 %
Longduoduo Co Ltd  152.69 %
Pavmed Inc   149.32 %
Champions Oncology Inc   127.02 %
Cytomx Therapeutics Inc   114.82 %
Oak Woods Acquisition Corp  84.43 %
Earth Science Tech Inc   81.05 %
Addex Therapeutics Ltd  75.10 %
Tao Synergies Inc   71.64 %

Date modified: 2026-09-08T15:11:25+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.